PAR News: We Think Paradigm Biopharmaceuticals (ASX:PAR) Can Afford To Drive Business Growth - 30th Jun 2022, 7:31am

annb0t

Top 20
We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt.

Given this risk, we thought we'd take a look at whether Paradigm Biopharmaceuticals (ASX:pAR) shareholders should be worried...

>>> Read more: We Think Paradigm Biopharmaceuticals (ASX:pAR) Can Afford To Drive Business Growth
 
Top Bottom